Consider Comorbid Health Conditions Patients with weight-related comorbidities such as type 2 diabetes, sleep apnea, or heart disease may be advised to continue GLP-1 therapy to manage these conditions in conjunction with weight loss
Authors Lobke Meels , Denise Slenter , Eline Sanders , Irene Hemel , Egon Willighagen , Friederike Ehrhart , Eric Weitz , and Finterly Hu Activity Discuss this pathway Check for ongoing discussions or start your own
Without clinical data, predicting individual tolerability is impossible
Additionally, Mounjaro , one of the newer diabetes drugs, which was approved in May 2022 and has a unique dual mechanism of action (it activates the GLP-1 hormone as well as another hormone called the glucose-dependent insulinotropic polypeptide or GIP, both helping to improve blood sugar) may be even more effective than semaglutide in reducing weight
Investigations aiming to assess the impact of perioperative gastric POCUS are still ongoing, with only very few published literature
Is Gluta C Glutathione effective for skin brightening, and what treatment can help safely